Table 1.
Demographic and Follow-up Data of the Groups
| Overall (N = 255) (Mean ± SD) | Group 1(N = 220) (Mean ± SD) | Group 2(N = 35) (Mean ± SD) | P-Value | |
|---|---|---|---|---|
| Age (years) | 65.18 ± 6.51 (45–80) | 65.32 ± 6.11 (45–78) | 67.14 ± 5.71 (55–80) | .134 |
| BMI2 (kg/m²) | 25.32 ± 3.02 (18–34) | 25.36 ± 2.99 (19–34) | 25.11 ± 3.22 (18–31) | .661 |
| Prostate volume (mL) | 52.40 ± 24.09 (18–220) | 52.57 ± 25.09 (18–220) | 51.35 ± 16.47 (25–85) | .785 |
| Preoperative T PSA (ng/mL) | 10.22 ± 7.51 (2.12–68) | 11.07 ± 4.28 (2.12–33.3) | 13.19 ± 10.44 (4.72–68) | .078 |
| Operative time (minutes) | 179.35 ± 32.33 (50–260) | 176.87 ± 32.05 (50–250) | 194.86 ± 30.4 (140–260) | .002 |
| Postoperative 3-month PSA | 0.12 ± 0.02 (0.00–1.69) | 0.11 ± 0.39 (0.00–1.69) | 0.09 ± 0.41 (0.01–0.81) | .067 |
| Blood loss (mL) | 178.90 ± 101.8 (50–600) | 175.14 ± 98.17 (50–500) | 159.86 ± 102.6 (50–600) | .054 |
| Drain duration (days) | 4.37 ± 0.93 (2–6) | 4.38 ± 0.94 (2–6) | 4.29 ± 0.86 (3–6) | .581 |
| Hospital stay (days) | 6.67 ± 1.71 (4–10) | 6.62 ± 1.69 (4–10) | 6.94 ± 1.80 (4–10) | .302 |
| Catheter duration (days) | 11.22 ± 2.27 (7–14) | 11.17 ± 2.31 (7–14) | 11.69 ± 1.98 (7–14) | .217 |
| VAS | 5.91 ± 1.23 (0–8) | 5.94 ± 1.22 (0–8) | 5.74 ± 1.31 (3–8) | .311 |
Group 1: ELRP in patients without a history of IHR; group 2: ELRP in patients with a history of IHR; SD, standard deviation; BMI, body mass index; PSA, prostate-specific antigen; VAS, visual analog scale.